Bill Sponsor
House Bill 5809
115th Congress(2017-2018)
Postoperative Opioid Prevention Act of 2018
Introduced
Introduced
Introduced in House on May 15, 2018
Overview
Text
Not Scanned for Linkage
About Linkage
Multiple bills can contain the same text. This could be an identical bill in the opposite chamber or a smaller bill with a section embedded in a larger bill.
Bill Sponsor regularly scans bill texts to find sections that are contained in other bill texts. When a matching section is found, the bills containing that section can be viewed by clicking "View Bills" within the bill text section.
Bill Sponsor is currently only finding exact word-for-word section matches. In a future release, partial matches will be included.
Not Scanned for Linkage
About Linkage
Multiple bills can contain the same text. This could be an identical bill in the opposite chamber or a smaller bill with a section embedded in a larger bill.
Bill Sponsor regularly scans bill texts to find sections that are contained in other bill texts. When a matching section is found, the bills containing that section can be viewed by clicking "View Bills" within the bill text section.
Bill Sponsor is currently only finding exact word-for-word section matches. In a future release, partial matches will be included.
H. R. 5809 (Introduced-in-House)


115th CONGRESS
2d Session
H. R. 5809


To amend title XVIII of the Social Security Act to encourage the use of non-opioid analgesics for the management of post-surgical pain under the Medicare program, and for other purposes.


IN THE HOUSE OF REPRESENTATIVES

May 15, 2018

Mr. Peters (for himself and Mr. Bucshon) introduced the following bill; which was referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned


A BILL

To amend title XVIII of the Social Security Act to encourage the use of non-opioid analgesics for the management of post-surgical pain under the Medicare program, and for other purposes.

Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,

SECTION 1. Short title.

This Act may be cited as the “Postoperative Opioid Prevention Act of 2018”.

SEC. 2. Medicare incentives for use of non-opioid analgesics in hospital outpatient departments and ambulatory surgical centers.

Section 1833(t)(6) of the Social Security Act (42 U.S.C. 1395l(t)(6)) is amended—

(1) in subparagraph (C)(i), by inserting “or, in the case of an eligible non-opioid analgesic (as defined in subparagraph (J)), during a period of 5 years,” after “3 years,”; and

(2) by adding at the end the following new subparagraph:

    “(J) ELIGIBLE NON-OPIOID ANALGESIC DEFINED.—In this paragraph, the term ‘eligible non-opioid analgesic’ means a drug or biological—

    “(i) that is an analgesic that is not an opioid;

    “(ii) that demonstrated substantial clinical improvement; and

    “(iii) for which payment—

    “(I) as an outpatient hospital service under this part was not being made as of the date of the enactment of this subparagraph; or

    “(II) was being made under this paragraph as of such date.”.